Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | NEU2 | Q9Y3R4 | 1/20 | 0.31 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2503406 | 0.89 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL7570134 | 0.89 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL12195138 | 0.89 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL5532821 | 0.89 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL8718037 | 0.89 | KMT2A (0.76) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL13742865 | 0.87 | KMT2A (0.50) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL21138778 | 0.86 | KMT2A (0.49) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL24236918 | 0.85 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL8584208 | 0.85 | KMT2A (0.70) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL7150056 | 0.85 | KMT2A (0.69) | KMT2AMEN1L3MBTL1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162252-A1 | SYNTHESIS OF 6-AZIDO-6-DEOXY-2-N-ACETYL-HEXOSAMINE-NUCLEOSIDE DIPHOSPHATE | SYNAFFIX B.V. (NL) | 2022-05-26 | — | — | US | disclosed |
| US-10927147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2021-02-23 | — | — | US | disclosed |
| US-10576147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2020-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162252-A1 | SYNTHESIS OF 6-AZIDO-6-DEOXY-2-N-ACETYL-HEXOSAMINE-NUCLEOSIDE DIPHOSPHATE | FUT6, NANS, B3GNT2 | KMT2A 3625/4885MEN1 3496/4885L3MBTL1 4501/4885 |
| US-10576147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | NOD2, HM13, QRFPR | KMT2A 2936/4885MEN1 854/4885L3MBTL1 2566/4885 |
| US-10927147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | NOD2, TLR9, MICA | KMT2A 2643/4885MEN1 1274/4885L3MBTL1 3921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.